FDA Warns About Semaglutide Overdoses

The popularity of weight loss drugs like Ozempic has surged nationwide, with pharmacies and doctors in Utah receiving daily inquiries. Originally intended for type 2 diabetes, Ozempic's weight loss benefits have led to high demand, sometimes outstripping supply and costing around $1,000 a month without insurance. The FDA has issued warnings about overdoses from compounded versions of semaglutide, the active ingredient in Ozempic, due to dosing errors from both patients and healthcare providers. These compounded drugs are not FDA-approved and pose higher risks, with reports of severe side effects and hospitalizations. Experts caution that while these drugs can help with weight loss, their effects are not permanent, and improper use can lead to significant health issues.